Furthermore, Western blot and Surface Plasmon Resonance (SPR) assays demonstrated that the anti-CRC effects of Sch A might be mediated through the direct interaction with HSF1 to suppress the expression of HSF1 downstream pro-oncogenic genes. This evidence concerns the gene HSF1 and colorectal carcinoma.